Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005
Report date:
2005

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
not specified
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
At the time that the study was conducted the M&K maximisation method was considered to be the most widely accepted for worldwide regulatory purposes.

Test material

Constituent 1
Chemical structure
Reference substance name:
D-serine
EC Number:
206-229-4
EC Name:
D-serine
Cas Number:
312-84-5
Molecular formula:
C3H7NO3
IUPAC Name:
D-serine
Test material form:
solid
Details on test material:
- Appearance: white solid
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Lot/batch No.of test material: K0498003
- Expiration date of the lot/batch: October 2005
- Purity: 100%

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature (storage temperature: from 16 to 25°C), dark place
- Stability: Stable under the storage conditions

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Age at study initiation: 6 weeks
- Weight at study initiation: 303 to 356 g

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Concentration / amount:
10%w/v
Adequacy of induction:
other: maximum concentration at which there was no necrosis.
Route:
intradermal
Vehicle:
other: Freund’s Complete Adjuvant and water
Concentration / amount:
1:1
Adequacy of induction:
not specified
Route:
intradermal
Vehicle:
other: test solution and Freund’s Complete Adjuvant
Concentration / amount:
20 w/v% Test solution and Freund’s Complete Adjuvant
Adequacy of induction:
not specified
Route:
other: Percutaneous
Vehicle:
not specified
Concentration / amount:
50 w/v% Test solution
Adequacy of induction:
highest technically applicable concentration used
Challengeopen allclose all
No.:
#1
Route:
other: not specified
Vehicle:
not specified
Concentration / amount:
50 w/v% Test solution
Day(s)/duration:
On day 20 after induction of sensitization
Adequacy of challenge:
highest non-irritant concentration
No.:
#2
Route:
other: not specified
Vehicle:
not specified
Concentration / amount:
5 w/v% Test solution
Day(s)/duration:
On day 20 after induction of sensitization
Adequacy of challenge:
not specified
No.:
#3
Route:
other: not specified
Vehicle:
not specified
Concentration / amount:
0.5 w/v% Test solution
Day(s)/duration:
On day 20 after induction of sensitization
Adequacy of challenge:
not specified
No.:
#4
Route:
other: not specified
Vehicle:
not specified
Concentration / amount:
0.05 w/v% Test solution
Day(s)/duration:
: On day 20 after induction of sensitization
Adequacy of challenge:
not specified
No.:
#5
Route:
other: not specified
Vehicle:
not specified
Concentration / amount:
0.005 w/v% Test solution
Day(s)/duration:
On day 20 after induction of sensitization
Adequacy of challenge:
not specified
No.:
#6
Route:
other: not specified
Vehicle:
not specified
Concentration / amount:
Water for injection
Day(s)/duration:
On day 20 after induction of sensitization
Adequacy of challenge:
not specified
No. of animals per dose:
Test article sensitization group: 10 animals
Test article non-sensitization group: 5 animals
Details on study design:
Intradermal induction: 10 w/v% (maximum concentration)
Percutaneous induction: 50 w/v% (maximum physically administrable concentration)
Challenge exposure: 0.005, 0.05, 0.5, 5, 50 w/v% ( maximum non-irritating concentration)
Challenge controls:
The skin was observed for skin reactions at 24 and 48 hours after removal of the application for challenge exposure, and erythema and edema graded based on the Standards of Magnusson & Kligman:
Severity of Skin Reactions Grade
No visible change 0
Discrete or patchy erythema 1
Moderate and confluent erythema 2
Intense erythema and swelling 3
Positive control substance(s):
yes
Remarks:
Historical background data of the positive control article

Results and discussion

Positive control results:
No positive control groups were provided in this study: historical background data of the positive control article (MBT: Mercaptobenzothiazole) using the same strain of guinea pigs were obtained at the test facility (April 7, 2004 to March 8, 2005) and it has been confirmed that the experimental technique of the test facility was appropriate and there is no problem in the susceptibility of the guinea pigs used in this study.

In vivo (non-LLNA)

Results
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50 w/v%
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
no indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
other: the substance is not a skin sensitiser
Conclusions:
Based on the results described above, it was concluded that the test substance had no skin sensitization effects under the conditions of this study.
Executive summary:

The skin sensitisation potential of the test material was investigated in a GLP study which was conducted in accordance with the standardised guideline OECD 406 following guinea pig maximisation test methods.

Under the conditions of the study there were no skin reactions in the observation at 24 or 48 hours after removal of challenge application in any test group during the observation period.

In the general condition and body weight, there were no abnormalities that are thought to be effects from administration of the test material in any test group during the observation period.

Based on the results described above, it was concluded that the test material had no skin sensitisation effects under the conditions of this study.